Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals
出版年份 2022 全文链接
标题
Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals
作者
关键词
-
出版物
Endocrine Practice
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2022-03-30
DOI
10.1016/j.eprac.2022.03.016
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Change from NAFLD to MAFLD increases the awareness of fatty liver disease in primary care physicians and specialists
- (2021) Yasser Fouad et al. JOURNAL OF HEPATOLOGY
- Therapeutic pipeline in nonalcoholic steatohepatitis
- (2021) Raj Vuppalanchi et al. Nature Reviews Gastroenterology & Hepatology
- Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study
- (2021) Madunil Anuk Niriella et al. PLoS One
- The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease
- (2021) Yuemin Nan et al. JOURNAL OF HEPATOLOGY
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
- (2021) Giovanni Targher et al. Lancet Gastroenterology & Hepatology
- Cardiovascular and renal burdens of metabolic associated fatty liver disease from serial US national surveys, 1999–2016
- (2021) Hao-Jie Zhang et al. CHINESE MEDICAL JOURNAL
- Metabolic dysfunction-associated fatty liver disease and mortality among Chinese adults: a prospective cohort study
- (2021) Xiaomo Wang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Association of MAFLD with diabetes, chronic kidney disease, and cardiovascular disease: a 4.6-year cohort study in China
- (2021) Yebei Liang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States
- (2021) Donghee Kim et al. JOURNAL OF HEPATOLOGY
- The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis
- (2021) Shanshan Liu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Risk stratification using sarcopenia status among subjects with metabolic dysfunction‐associated fatty liver disease
- (2021) Ho Soo Chun et al. Journal of Cachexia Sarcopenia and Muscle
- Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases
- (2021) Mohammed Eslam et al. Lancet Gastroenterology & Hepatology
- NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?—Results From NHANES III
- (2021) Qi Huang et al. Frontiers in Medicine
- Is Fatty Liver Associated With Depression? A Meta-Analysis and Systematic Review on the Prevalence, Risk Factors, and Outcomes of Depression and Non-alcoholic Fatty Liver Disease
- (2021) Jieling Xiao et al. Frontiers in Medicine
- An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD
- (2021) Grace En Hui Lim et al. Clinical Gastroenterology and Hepatology
- Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease
- (2021) Joon Ho Moon et al. Gut and Liver
- Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case–control study
- (2021) Hui-Hui Liu et al. Hepatology International
- Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan
- (2021) Masato Yoneda et al. JOURNAL OF GASTROENTEROLOGY
- The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
- (2021) Jeffrey V. Lazarus et al. JOURNAL OF HEPATOLOGY
- Metabolic dysfunction–associated fatty liver disease and the risk of 24 specific cancers
- (2021) Zhenqiu Liu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Advancing the global public health agenda for NAFLD: a consensus statement
- (2021) Jeffrey V. Lazarus et al. Nature Reviews Gastroenterology & Hepatology
- Metabolic associated fatty liver disease is a risk factor for chronic kidney disease
- (2021) Yoshitaka Hashimoto et al. Journal of Diabetes Investigation
- Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis
- (2021) Rohit Loomba et al. GASTROENTEROLOGY
- Nonalcoholic Fatty Liver Disease: What Does the Primary Care Physician Need to Know?
- (2020) Jeffrey Budd et al. AMERICAN JOURNAL OF MEDICINE
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- From NAFLD to MAFLD: when pathophysiology succeeds
- (2020) Herbert Tilg et al. Nature Reviews Gastroenterology & Hepatology
- The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. Hepatology International
- Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study
- (2020) Hokyou Lee et al. Clinical Gastroenterology and Hepatology
- MAFLD and risk of CKD
- (2020) Dan-Qin Sun et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
- (2019) Donna K. Arnett et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Past, present and future perspectives in nonalcoholic fatty liver disease
- (2019) Arun J. Sanyal Nature Reviews Gastroenterology & Hepatology
- Fixed and random effects models: making an informed choice
- (2018) Andrew Bell et al. QUALITY & QUANTITY
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
- (2015) Brian Hutton et al. ANNALS OF INTERNAL MEDICINE
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
- (2015) Xiang Wan et al. BMC Medical Research Methodology
- The global NAFLD epidemic
- (2013) Rohit Loomba et al. Nature Reviews Gastroenterology & Hepatology
- Chronic kidney disease
- (2011) Andrew S Levey et al. LANCET
- Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link?
- (2010) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Hospital-based comprehensive cardiac rehabilitation versus usual care among patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease: 12-Month results of a randomized clinical trial
- (2008) Ann-Dorthe Olsen Zwisler et al. AMERICAN HEART JOURNAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started